WASHINGTON (Reuters) - The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid ...

After years of surgeries, powerful medications, and debilitating symptoms, Hadley Ott decided to take a different path in managing his Crohn's disease. Today, the 28-year-old says he has been ...

BOSTON (MarketWatch) - The Food and Drug Administration has approved Johnson & Johnson's rheumatoid arthritis drug Remicade for the treatment of ulcerative colitis, a debilitating digestive disease.

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

A drug wholesaler is urging a federal appeals court to not send a lawsuit accusing Johnson & Johnson of seeking to suppress competition for its blockbuster rheumatoid arthritis drug Remicade to ...

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Centocor have warned healthcare professionals via letter regarding risks of hepatotoxicity and pneumonia associated with the use of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo clearance to ProciseDx Inc. for its therapeutic drug monitoring tests for Humira and ...

A delay for a critical medication resulted in a $50,000 surgical nightmare. Here is how health care bureaucratic delays ...